Article

jdsupra.com on 2022-09-30 20:10

FDA Publishes Draft Ethical Consideration Guidance to Protect Children Participants in Clinical Trials of Medical Products

On September 23, 2022, the Food and Drug Administration (FDA) published a draft guidance aimed to protect children who participate in clinical trials, ...

Related news

FDA Publishes First Draft Guidance for Clinical Trials with Psychedelic Drugs jdsupra.com
Willis-Knighton Seeks Participants for Clinical Trials of COVID-19 Treatments bossierpress.com
Decentralized Clinical Trials: Diversity in Clinical Trials jdsupra.com
Pacific Ocean
Clinical trials: Skewing medical science The Economist
Americas , Europe , United States
Decentralized Clinical Trials: Investigator Responsibilities jdsupra.com
Houston
Decentralized Clinical Trials: Sponsor Responsibilities jdsupra.com
'Crowd-Sourcing Knowledge' to Revolutionize Clinical Trials prescottenews.com
Washington , Australia , China , United States
Clinical trials exclude too many patients Dallas News
Dallas , Washington
Psychedelic Breakthroughs: Key Considerations for Clinical Trials jdsupra.com
Fully , The Center
FDA clears ALung device for clinical trials bizjournals.com
A Cancer Patient’s Guide to Clinical Trials ProPublica
Shattering Misperceptions of Blacks and Clinical Trials sacobserver.com
Philadelphia , Tuskegee , United States
Melanoma Cancer Vaccine Nearing Advanced Clinical Trials westsidetoday.com
Demystifying clinical trials and their impact bizjournals.com
Phase 4 , Phase 2 , Phase 1 , San Antonio
MedidataVoice: Clinical Trials In The Real World Forbes
Americas , United States
Meharry, Vanderbilt Clinical COVID-19 Trials Seek Local Participants tntribune.com
Nashville , United Arab Emirates , China , Spain , United Kingdom
European Commission publishes new documents regarding the Clinical Trials Regulation jdsupra.com
California , United States , Switzerland
European Commission Publishes Updated Q&A on Clinical Trials Regulation jdsupra.com
Ethical AI Can Promote Diversity In Clinical Research Forbes
Bias